Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity and Persistence of Intramuscular High Dose Recombinant Hepatitis B Vaccine in HIV-infected Adults in China

NCT03316807 is registered in ClinicalTrials.gov with Suping Wang as lead sponsor.

NCT NCT03316807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03316807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity and Persistence of Intramuscular High Dose Recombinant Hepatitis B Vaccine in HIV-infected Adults in China
Lead sponsor
Suping Wang
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2014
Completion date
July 31, 2018
Enrollment
182 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b vaccine